Autor: "Graff C" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Autorzy:: Swift IJ; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.; VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Finch N; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Baker M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Ghidoni R; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Benussi L; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Binetti G; MAC-Memory Clinic and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Rossi G; Unit of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Synofzik M; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Wilke C; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Mengel D; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Graff C; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, BioclinicumKarolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Inflammation and Aging, Karolinska University Hospital, Solna, Sweden.
Takada LT; Department of Neurology, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.
Sánchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Antonell A; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Galimberti D; Dept. of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Fenoglio C; Dept. of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Serpente M; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Arcaro M; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Schreiber S; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Vielhaber S; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Arndt P; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Santana I; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Almeida MR; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Barandiaran M; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Gabilondo A; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Stubert J; Department of Obstetrics and Gynecology, Rostock University Medical Center, Rostock, Germany.
Gómez-Tortosa E; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Agüero P; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Sainz MJ; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Gohda T; Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Murakoshi M; Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Kamei N; Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomicbomb Survivors Hospital, Hiroshima, Japan.; Institute for Clinical Research, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Kittel-Schneider S; Department of Psychiatry, University College Cork, Cork, Ireland.; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Würzburg, Würzburg, Germany.
Reif A; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Frankfurt, Frankfurt, Germany.
Weigl J; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Würzburg, Würzburg, Germany.; Department of Psychiatry, Hospital in Tauberbischofsheim, Tauberbischofsheim, Germany.
Jian J; University of Pennsylvania, Gene Therapy Program, Philadelphia, USA.
Liu C; Department of Orthopaedics & Rehabilitation, Yale University School of Medicine, New Haven, CT, USA.
Serrero G; A&G Pharmaceutical Inc, Columbia, MD, USA.; Program in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Greither T; Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Theil G; Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Lohmann E; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany.
Gazzina S; Department of Neurological and Vision Sciences, Neurophysiology Unit, ASST SpedaliCivili, Brescia, Italy.
Bagnoli S; Department of Neurological and Psychiatric Sciences, University of Florence, Viale Morgagni, 85, 50134, Florence, Italy.
Coppola G; Department of Neurology, University of California, Los Angeles, California, USA.; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California, USA.
Bruni A; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Quante M; Department of Neonatology, Tuebingen University Hospital, Tuebingen, Germany.
Kiess W; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.; Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.; Center of Pediatric Research (CPL), University of Leipzig, Leipzig, Germany.
Hiemisch A; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.; Center of Pediatric Research (CPL), University of Leipzig, Leipzig, Germany.
Jurkutat A; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.
Block MS; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Carlson AM; Department of Neurology, University of Colorado Anschutz Medical Campus, Denver, CO, USA.
Bråthen G; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Sando SB; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Grøntvedt GR; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Lauridsen C; Department of Research, Trondheim University Hospital, Trondheim, Norway.
Heslegrave A; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.
Heller C; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Abel E; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.
Gómez-Núñez A; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Puey R; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Arighi A; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Rotondo E; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Jiskoot LC; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Meeter LHH; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Durães J; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.
Lima M; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.
Tábuas-Pereira M; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Lemos J; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Boeve B; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Petersen RC; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
LeBer I; Sorbonne UniversitéInserm U1127, CNRS UMR 7225, Institut du Cerveau Et La Moelle Épinière (ICM), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Sellami L; Sorbonne UniversitéInserm U1127, CNRS UMR 7225, Institut du Cerveau Et La Moelle Épinière (ICM), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Centre de Référence Des Démences Rares Ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Lamari F; UF de Biochimie Des Maladies Neurométaboliques Et Neurodégénératives, Service de Biochimie Métabolique, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Clot F; UF de Neurogénétique Moléculaire Et Cellulaire, Département de Génétique, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, France.
Borroni B; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Cantoni V; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Rivolta J; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Lleó A; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Fortea J; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Alcolea D; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Illán-Gala I; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Andres-Cerezo L; Institute of Rheumatology, Na Slupi 4, 12850, Prague 2, Prague, Czech Republic.
Van Damme P; Laboratory of Neurobiology, Flanders Interuniversity Institute for Biotechnology, Katholieke Universiteit Leuven, Campus Gasthuisberg, 3000, Louvain, Belgium.
Clarimon J; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Memory Unit, Department of Neurology, Institut d'Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Steinacker P; Department of Neurology, Martin-Luther University Halle-Wittenberg, University Clinic Halle, Halle (Saale), Germany.
Feneberg E; Department of Neurology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
Otto M; Department of Neurology, Martin-Luther University Halle-Wittenberg, University Clinic Halle, Halle (Saale), Germany.
van der Ende EL; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
van Swieten JC; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Seelaar H; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Zetterberg H; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, University College London, London, UK.; Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
Sogorb-Esteve A; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. .; Pokaż więcej
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Mar 28; Vol. 16 (1), pp. 66. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Frontotemporal Dementia*/genetics
Frontotemporal Dementia*/pathology
Male ; Humans ; Female ; Progranulins/genetics ; Intercellular Signaling Peptides and Proteins/genetics ; Virulence ; Mutation/genetics ; Membrane Proteins/genetics ; Nerve Tissue Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Diagnostic accuracy of research criteria for prodromal frontotemporal dementia.
Autorzy:: Benussi A; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.; Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili di Brescia, 25123, Brescia, Italy.
Premi E; Vascular Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili di Brescia, 25123, Brescia, Italy.
Grassi M; Department of Brain and Behavioral Science, Medical and Genomic Statistics Unit, University of Pavia, 27100, Pavia, Italy.
Alberici A; Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili di Brescia, 25123, Brescia, Italy.
Cantoni V; Department of Molecular and Translational Medicine, University of Brescia, 25123, Brescia, Italy.
Gazzina S; Department of Neurological and Vision Sciences, Neurophysiology Unit, ASST Spedali Civili di Brescia, 25123, Brescia, Italy.
Archetti S; Biotechnology Laboratory, Department of Diagnostics, ASST Spedali Civili di Brescia, 25123, Brescia, Italy.
Gasparotti R; Department of Medical and Surgical Specialties, Neuroradiology Unit, University of Brescia, 25123, Brescia, Italy.
Fumagalli GG; Center for Mind/Brain Sciences-CIMeC, University of Trento, 38068, Rovereto, Italy.
Bouzigues A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Russell LL; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Samra K; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Cash DM; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Bocchetta M; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Todd EG; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Convery RS; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Swift I; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.
Sogorb-Esteve A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.
Heller C; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.
van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, 3015 GD, The Netherlands.
Jiskoot LC; Department of Neurology, Erasmus Medical Centre, Rotterdam, 3015 GD, The Netherlands.
Seelaar H; Department of Neurology, Erasmus Medical Centre, Rotterdam, 3015 GD, The Netherlands.
Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, 08036, Barcelona, Spain.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, 20014, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, 20014, San Sebastian, Gipuzkoa, Spain.
Laforce RJ; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Facultéde Médecine, Université Laval, Quebec City, Québec, G1V 0A6, Canada.
Graff C; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, 141 52, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, 141 52, Solna, Sweden.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tubingen, 72076, Tubingen, Germany.; Center for Neurodegenerative Diseases (DZNE), 72076, Tübingen, Germany.
Galimberti D; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 20122, Milan, Italy.; Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122, Milan, Italy.
Rowe JB; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, CB2 7EF, UK.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, ON, M4N 3M5, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, M5S, Canada.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, N6A 3K7, Canada.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, 3001, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, 3000, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3001, Leuven, Belgium.
Mendonça A; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Tiraboschi P; Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133, Milan, Italy.
Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, OX3 9DU, UK.; Department of Brain Sciences, Imperial College London, London, SW7 2BX, UK.
Santana I; Neurology Service, Faculty of Medicine, University Hospital of Coimbra (HUC), University of Coimbra, 3004-561, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, 3004-561, Coimbra, Portugal.
Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, M20 3LJ, UK.; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, 47057, Essen, Germany.; Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK.
Le Ber I; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, 75013, Paris, France.; Centre de référence des démences rares ou précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, 75013, Paris, France.; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, 75013, Paris, France.
Pasquier F; Univ Lille, 59000, Lille, France.; Inserm 1172, 59000, Lille, France.; CHU, CNR-MAJ, Labex Distalz, LiCEND Lille, 59000, Lille, France.
Ducharme S; Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, H3A 1A1, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, Department of Neurology & Neurosurgery, McGill University, Montreal, H3A 2B4, Canada.
Levin J; Neurologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, 80539, Munich, Germany.; Center for Neurodegenerative Diseases (DZNE), 81377, Munich, Germany.; Munich Cluster of Systems Neurology, 81377, Munich, Germany.
Sorbi S; Department of Neurofarba, University of Florence, 50139, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, 50143, Florence, Italy.
Otto M; Department of Neurology, University of Ulm, 89081, Ulm, Germany.
Padovani A; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy.; Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili di Brescia, 25123, Brescia, Italy.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London, WC1E 6BT, UK.
Borroni B; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili 1, 25123, Brescia, Italy. .; Neurology Unit, Department of Neurological and Vision Sciences, ASST Spedali Civili di Brescia, 25123, Brescia, Italy. .; Pokaż więcej
Corporate Authors:: Genetic Frontotemporal dementia Initiative (GENFI)
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Jan 12; Vol. 16 (1), pp. 10. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Frontotemporal Dementia*/diagnosis
Frontotemporal Dementia*/genetics
Humans ; Neurofilament Proteins ; Biomarkers ; Atrophy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Altered plasma protein profiles in genetic FTD - a GENFI study.
Autorzy:: Ullgren A; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital, Solna, Sweden.
Öijerstedt L; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital, Solna, Sweden.
Olofsson J; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Bergström S; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Remnestål J; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Jiskoot LC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Seelaar H; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Borroni B; Department of Clinical and Experimental Sciences, Centre for Neurodegenerative Disorders, University of Brescia, Brescia, Italy.
Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Moreno F; Department of Neurology, Cognitive Disorders Unit, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.
Laforce R; Département Des Sciences Neurologiques, Clinique Interdisciplinaire de Mémoire, CHU de Québec, and Faculté de Médecine, Université Laval, Quebec City, QC, Canada.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Galimberti D; Fondazione IRCCS Ospedale Policlinico, Milan, Italy.; University of Milan, Centro Dino Ferrari, Milan, Italy.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada.
Vandenberghe R; Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.
de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Tirabosch P; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Santana I; Faculty of Medicine, University Hospital of Coimbra (HUC), Neurology Service, University of Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Ducharme S; Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Québec, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.; Department of Brain Sciences, Imperial College London, London, UK.
Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.; Departments of Geriatric Medicine and Nuclear Medicine, Center for Translational Neuro- and Behavioral Sciences, University Medicine Essen, Essen, Germany.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Bouzigues A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK.
Russell L; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK.
Swift IJ; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK.
Sogorb-Esteve A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK.
Heller C; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK.
Månberg A; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Nilsson P; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
Graff C; Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden. caroline.graff@ki.se.; Unit for Hereditary Dementias, Karolinska University Hospital, Solna, Sweden. caroline.graff@ki.se.; Pokaż więcej
Corporate Authors:: Genetic Frontotemporal Dementia Initiative (GENFI)
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2023 Nov 15; Vol. 18 (1), pp. 85. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:: Journal Article
MeSH Terms:: Frontotemporal Dementia*/genetics
Frontotemporal Dementia*/pathology
Humans ; Mutation/genetics ; C9orf72 Protein/genetics ; Progranulins/genetics ; tau Proteins/genetics ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia.
Autorzy:: Woollacott IOC; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Swift IJ; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom.
Sogorb-Esteve A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom.
Heller C; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom.
Knowles K; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom.
Bouzigues A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Russell LL; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Peakman G; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Greaves CV; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Convery R; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.
Heslegrave A; UK Dementia Research Institute at UCL, London, United Kingdom.
Rowe JB; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom.
Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Galimberti D; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Tiraboschi P; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Seelaar H; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Jiskoot L; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Sorbi S; Department of Neurofarba, University of Florence, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.; Department of Brain Sciences, Imperial College London, United Kingdom.
Graff C; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, United Kingdom.; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Essen, Germany.; Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, United Kingdom.
Laforce R; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, Québec, Canada.
Sanchez-Valle R; Alzheimer's disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Ducharme S; Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, Department of Neurology & Neurosurgery, McGill University, Montreal, Canada.
Ber IL; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Centre de référence des démences rares ou précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Levin J; Neurologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Munich, Germany.; Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster of Systems Neurology, Munich, Germany.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Pasquier F; Univ Lille, Lille, France.; Inserm 1172, Lille, France.; CHU, CNR-MAJ, Labex Distalz, LiCEND Lille, Lille, France.
Santana I; Neurology Service, Faculty of Medicine, University Hospital of Coimbra (HUC), University of Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Zetterberg H; UK Dementia Research Institute at UCL, London, United Kingdom.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, United Kingdom.; UK Dementia Research Institute at UCL, London, United Kingdom.; Pokaż więcej
Corporate Authors:: Genetic FTD Initiative, GENFI
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Nov; Vol. 9 (11), pp. 1764-1777. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Frontotemporal Dementia*/diagnosis
Pick Disease of the Brain*
Humans ; C9orf72 Protein/genetics ; Chitinase-3-Like Protein 1/genetics ; Biomarkers/cerebrospinal fluid ; Neuroglia

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.
Autorzy:: van der Ende EL; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Heller C; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Sogorb-Esteve A; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Swift IJ; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
McFall D; Department of Pathology, University of California San Francisco, San Francisco, USA.
Peakman G; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Bouzigues A; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Poos JM; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Jiskoot LC; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Panman JL; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Papma JM; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Meeter LH; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Dopper EGP; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Bocchetta M; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Todd E; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Cash D; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Graff C; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Synofzik M; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Hospital Universitario Donostia, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada.
Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Louvain, Belgium.
Laforce R Jr; Clinique Interdisciplinaire de Mémoire, Département Des Sciences Neurologiques, CHU de Québec, Université Laval, Québec, Canada.
Masellis M; Sunnybrook Research Institute, Toronto, ON, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, ON, Canada.
Rowe JB; Cambridge University Centre for Frontotemporal Dementia, University of Cambridge, Cambridge, UK.
Butler C; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Ducharme S; McConnell Brain Imaging Centre, Montreal Neurological Institute and McGill University Health Centre, McGill University, Montreal, Québec, Canada.
Gerhard A; Department of Nuclear Medicine and Geriatric Medicine, University Hospital Essen, Essen, Germany.; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.
Danek A; Neurologische Klinik Und Poliklinik, Ludwig-Maximilians-Universität München, Munich, Germany.
Levin J; Neurologische Klinik Und Poliklinik, Ludwig-Maximilians-Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Pijnenburg YAL; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Otto M; Department of Neurology, Universität Ulm, Ulm, Germany.
Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Tagliavini F; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
de Mendonça A; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Santana I; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Galimberti D; Fondazione IRCCS, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy.; University of Milan, Centro Dino Ferrari, Milan, Italy.
Sorbi S; Department of Neurofarba, University of Florence, Florence, Italy.
Zetterberg H; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Huang E; Department of Pathology, University of California San Francisco, San Francisco, USA.
van Swieten JC; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.
Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
Seelaar H; Alzheimer Center Rotterdam and Department of Neurology, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. .; Pokaż więcej
Corporate Authors:: Genetic Frontotemporal Dementia Initiative (GENFI)
Źródło:: Journal of neuroinflammation [J Neuroinflammation] 2022 Sep 05; Vol. 19 (1), pp. 217. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:: Journal Article
MeSH Terms:: Frontotemporal Dementia*/diagnostic imaging
Frontotemporal Dementia*/genetics
Pick Disease of the Brain*
Biomarkers ; C9orf72 Protein/genetics ; Cohort Studies ; Complement C1q ; Complement System Proteins/genetics ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia.
Autorzy:: Sogorb-Esteve A; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Nilsson J; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.
Swift IJ; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Heller C; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Bocchetta M; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Russell LL; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Peakman G; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Convery RS; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Seelaar H; Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Galimberti D; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital ClínicInstitut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Laforce R Jr; Clinique Interdisciplinaire de MémoireDépartement Des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, Quebec City, QC, Canada.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Graff C; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, BioclinicumKarolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
Rowe JB; Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust and Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Louvain, Belgium.; Neurology Service, University Hospitals Leuven, Louvain, Belgium.; Leuven Brain Institute, KU Leuven, Louvain, Belgium.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada.
Tagliavini F; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Santana I; Faculty of Medicine, University Hospital of Coimbra (HUC), Neurology Service, University of Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.; Department of Brain Sciences, Imperial College London, London, UK.
Ducharme S; Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Canada.; McConnell Brain Imaging Centre, Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada.
Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.
Danek A; Neurologische Klinik Und Poliklinik, Ludwig-Maximilians-Universität, Munich, Germany.
Levin J; Neurologische Klinik Und Poliklinik, Ludwig-Maximilians-Universität, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster of Systems Neurology, Munich, Germany.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Sorbi S; Department of Neurofarba, University of Florence, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Le Ber I; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Centre de Référence Des Démences Rares Ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Reference Network for Rare Neurological Diseases (ERN-RND), Tübingen, Germany.
Pasquier F; University of Lille, Lille, France.; Inserm, 1172, Lille, France.; CHU, CNR-MAJ, Labex Distalz, LiCEND, Lille, France.
Gobom J; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Brinkmalm A; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Blennow K; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Zetterberg H; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK.; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong Kong Center for Neurodegenerative Diseases, Sha Tin, Hong Kong, China.
Rohrer JD; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, London, UK. .; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK. .; Pokaż więcej
Corporate Authors:: GENetic FTD Initiative
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2022 Aug 31; Vol. 14 (1), pp. 118. Date of Electronic Publication: 2022 Aug 31.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Frontotemporal Dementia*/cerebrospinal fluid
Frontotemporal Dementia*/genetics
Biomarkers/cerebrospinal fluid ; C9orf72 Protein/cerebrospinal fluid ; C9orf72 Protein/genetics ; Humans ; Mutation/genetics ; Neurogranin/cerebrospinal fluid ; Neurogranin/genetics ; Syntaxin 1/cerebrospinal fluid ; Syntaxin 1/genetics ; beta-Synuclein/genetics ; gamma-Synuclein/cerebrospinal fluid ; gamma-Synuclein/genetics ; tau Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The CBI-R detects early behavioural impairment in genetic frontotemporal dementia.
Autorzy:: Nelson A; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Russell LL; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Peakman G; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Convery RS; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Bouzigues A; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Greaves CV; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Bocchetta M; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Cash DM; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Jiskoot L; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia Universitary Hospital, San Sebastian, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.
Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Laforce R; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, Québec, Canada.
Graff C; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Borroni B; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE, Tübingen, Germany.
Galimberti D; Fondazione Ca' Granda, IRCCS Ospedale Policlinico, Milan, Italy.; University of Milan, Centro Dino Ferrari, Milan, Italy.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.
de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.; Department of Brain Sciences, Imperial College London, London, UK.
Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.
Ducharme S; Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, QC, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Le Ber I; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Département de Neurologie, Centre de référence des démences rares ou précoces, IM2A, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Reference Network for Rare Neurological Diseases (ERN-RND), European Union.
Santana I; University Hospital of Coimbra (HUC), Neurology Service, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Pasquier F; Univ Lille, Lille, France.; Inserm 1172, Lille, France.; CHU, CNR-MAJ, Labex Distalz, LiCEND Lille, Lille, France.
Levin J; Department of Neurology, Ludwig-Maximilians Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Sorbi S; Department of Neurofarba, University of Florence, Florence, Italy.; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; Pokaż więcej
Corporate Authors:: Genetic FTD Initiative (GENFI)
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 May; Vol. 9 (5), pp. 644-658. Date of Electronic Publication: 2022 Mar 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Frontotemporal Dementia*/diagnosis
Frontotemporal Dementia*/genetics
Pick Disease of the Brain*
C9orf72 Protein/genetics ; Humans ; Progranulins/genetics ; tau Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Cognitive composites for genetic frontotemporal dementia: GENFI-Cog.
Autorzy:: Poos JM; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Dementia Research Centre, Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, 8-11 Queen Square, Box 16, London, WC1N 3BG, UK.
Moore KM; Dementia Research Centre, Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, 8-11 Queen Square, Box 16, London, WC1N 3BG, UK.
Nicholas J; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Russell LL; Dementia Research Centre, Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, 8-11 Queen Square, Box 16, London, WC1N 3BG, UK.
Peakman G; Dementia Research Centre, Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, 8-11 Queen Square, Box 16, London, WC1N 3BG, UK.
Convery RS; Dementia Research Centre, Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, 8-11 Queen Square, Box 16, London, WC1N 3BG, UK.
Jiskoot LC; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Dementia Research Centre, Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, 8-11 Queen Square, Box 16, London, WC1N 3BG, UK.
van der Ende E; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
van den Berg E; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Papma JM; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Seelaar H; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Pijnenburg YAL; Department of Neurology, Alzheimer Center, Amsterdam University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.
Sanchez-Valle R; Alzheimer's disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Borroni B; Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Laforce R; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, Canada.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia C; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
Graff C; Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden.
Galimberti D; University of Milan, Centro Dino Ferrari, Milan, Italy.; Neurodegenerative Diseases Unit, Fondazione IRCCS Ca' Granda, Ospedale Policlinico, Milan, Italy.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Tiraboschi P; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologica Carlo Besta, Milan, Italy.
Santana I; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Ducharme S; Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Québec, Canada.
Butler C; Department of Clinical Neurology, University of Oxford, Oxford, UK.
Gerhard A; Faculty of Medical and Human Sciences, Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.
Levin J; Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Danek A; Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Le Ber I; Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.; Centre de référence des démences rares ou précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Pasquier F; University of Lille, Lille, France.; Inserm 1172, Lille, France.; CHU, CNR-MAJ, Labex Distalz, LiCEND, Lille, France.
van Swieten JC; Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, 8-11 Queen Square, Box 16, London, WC1N 3BG, UK. .; Pokaż więcej
Corporate Authors:: Genetic FTD Initiative (GENFI)
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2022 Jan 19; Vol. 14 (1), pp. 10. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Frontotemporal Dementia*/diagnosis
Frontotemporal Dementia*/genetics
Cognition ; Humans ; Mutation/genetics ; Neuropsychological Tests ; Prodromal Symptoms ; Sample Size ; tau Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort.
Autorzy:: Moore K; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Convery R; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Bocchetta M; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Neason M; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Cash DM; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Greaves C; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Russell LL; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Clarke MTM; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Peakman G; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
van Swieten J; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Jiskoot L; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Spain.
Barandiaran M; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Spain.
Sanchez-Valle R; Alzheimer's disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Borroni B; Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Laforce R Jr; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, Canada.
Doré MC; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, Canada.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
Graff C; Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden.
Galimberti D; Centro Dino Ferrari, University of Milan, Milan, Italy.; Neurodegenerative Diseases Unit, Ospedale Policlinico, Fondazione IRCCS Ca' Granda, Milan, IT.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Karnath HO; Division of Neuropsychology, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Maruta C; Faculty of Medicine, Laboratory of Language Research, Centro de Estudos Egas Moniz, University of Lisbon, Lisbon, Portugal.
Tagliavini F; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Neurologica Carlo Besta, Milano, Italy.
Santana I; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Ducharme S; Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Canada.
Butler C; Department of Clinical Neurology, University of Oxford, Oxford, UK.
Gerhard A; Faculty of Medical and Human Sciences, Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.
Levin J; Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Danek A; Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Warren JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, London, UK.; Pokaż więcej
Corporate Authors:: Genetic FTD Initiative, GENFI*
Źródło:: Applied neuropsychology. Adult [Appl Neuropsychol Adult] 2022 Jan-Feb; Vol. 29 (1), pp. 112-119. Date of Electronic Publication: 2020 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Cactaceae*
Frontotemporal Dementia*/complications
Frontotemporal Dementia*/genetics
Animals ; C9orf72 Protein ; Camelus ; Humans ; Progranulins ; Semantics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.
Autorzy:: Bergström S; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Öijerstedt L; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Unit of Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Remnestål J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Olofsson J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Ullgren A; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Unit of Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Seelaar H; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Sanchez-Valle R; Alzheimer's disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia C; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Laforce R; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, QC, Canada.
Galimberti D; Fondazione IRCCS Ospedale Policlinico, Milan, Italy.; University of Milan, Centro Dino Ferrari, Milan, Italy.
Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.; Department of Brain Sciences, Imperial College London, London, UK.
Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg- Essen, Duisburg, Germany.
Ducharme S; Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Québec, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.
Månberg A; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Graff C; Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Unit of Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden. caroline.graff@ki.se.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden. caroline.graff@ki.se.
Nilsson P; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden. .; Swedish FTD Initiative, Stockholm, Sweden. .; Pokaż więcej
Corporate Authors:: Genetic Frontotemporal Dementia Initiative (GENFI)
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2021 Nov 27; Vol. 16 (1), pp. 79. Date of Electronic Publication: 2021 Nov 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Frontotemporal Dementia*/genetics
Biomarkers ; Brain ; Humans ; Mutation/genetics ; Progranulins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia.
Autorzy:: Natarajan K; Division for Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden. .; Unit for Hereditary Dementias, Clinical Genetics, Karolinska University Hospital-Solna, Stockholm, Sweden. .
Eisfeldt J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Science for Life Laboratory, Karolinska Institutet Science Park, Solna, Sweden.
Hammond M; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Laffita-Mesa JM; Division for Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Clinical Genetics, Karolinska University Hospital-Solna, Stockholm, Sweden.
Patra K; Division for Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Clinical Genetics, Karolinska University Hospital-Solna, Stockholm, Sweden.
Khoshnood B; Division for Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Clinical Genetics, Karolinska University Hospital-Solna, Stockholm, Sweden.
Öijerstedt L; Division for Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Clinical Genetics, Karolinska University Hospital-Solna, Stockholm, Sweden.
Graff C; Division for Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden. caroline.graff@ki.se.; Unit for Hereditary Dementias, Clinical Genetics, Karolinska University Hospital-Solna, Stockholm, Sweden. caroline.graff@ki.se.; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2021 Aug 03; Vol. 9 (1), pp. 132. Date of Electronic Publication: 2021 Aug 03.
Typ publikacji:: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Penetrance*
Chromatin/*metabolism
Frontal Lobe/*metabolism
Frontotemporal Dementia/*genetics
Microglia/*metabolism
Progranulins/*genetics
Aged, 80 and over ; Female ; Frontal Lobe/pathology ; Frontotemporal Dementia/metabolism ; Frontotemporal Dementia/pathology ; Gene Expression Profiling ; Heterozygote ; Histones/metabolism ; Humans ; Microglia/pathology ; Mutation ; Progranulins/metabolism ; Single-Cell Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort.
Autorzy:: Franklin HD; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Russell LL; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Peakman G; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Greaves CV; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Bocchetta M; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Nicholas J; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Poos J; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Convery RS; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Cash DM; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
van Swieten J; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Jiskoot L; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.
Sanchez-Valle R; Alzheimer's disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Borroni B; Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Laforce R Jr; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, Québec, QC, Canada.
Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
Graff C; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.
Galimberti D; Fondazione Ca' Granda, IRCCS Ospedale Policlinico, Milan, Italy.; University of Milan, Centro Dino Ferrari, Milan, Italy.
Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.
Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.
de Mendonça A; Laboratory of Neurosciences, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
Tagliavini F; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Santana I; University Hospital of Coimbra (HUC), Neurology Service, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Ducharme S; Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Québec, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
Butler C; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.
Levin J; Department of Neurology, Ludwig-Maximilians Universität München, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
Danek A; Department of Neurology, Ludwig-Maximilians Universität München, Munich, Germany.
Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
Sorbi S; Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.; IRCCS Don Gnocchi, Firenze, Italy.
Le Ber I; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Centre de référence des démences rares ou précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Pasquier F; Univ Lille, Lille, France.; Inserm 1172, Lille, France.; CHU, CNR-MAJ, Labex Distalz, LiCEND, Lille, France.
Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, WC1N 3BG, UK. .; Pokaż więcej
Corporate Authors:: Genetic FTD Initiative, GENFI
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Jul 12; Vol. 13 (1), pp. 127. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Frontotemporal Dementia*/diagnostic imaging
Frontotemporal Dementia*/genetics
C9orf72 Protein/genetics ; Humans ; Magnetic Resonance Imaging ; Mutation/genetics ; Progranulins/genetics ; Social Cognition ; tau Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.
Autorzy:: Remnestål J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Öijerstedt L; Swedish FTD Initiative, Stockholm, Sweden.; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64, Solna, Sweden.; Unit for hereditary dementias, Theme Aging, Karolinska University Hospital, Stockholm, Sweden.
Ullgren A; Swedish FTD Initiative, Stockholm, Sweden.; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64, Solna, Sweden.
Olofsson J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Bergström S; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Kultima K; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Ingelsson M; Department of Public Health and Caring Sciences, Geriatrics, Uppsala University, Uppsala, Sweden.
Kilander L; Department of Public Health and Caring Sciences, Geriatrics, Uppsala University, Uppsala, Sweden.
Uhlén M; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Department of Neuroscience, Karolinska Institutet, Solna, Sweden.
Månberg A; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden.
Graff C; Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64, Solna, Sweden. caroline.graff@ki.se.; Unit for hereditary dementias, Theme Aging, Karolinska University Hospital, Stockholm, Sweden. caroline.graff@ki.se.
Nilsson P; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden. .; Swedish FTD Initiative, Stockholm, Sweden. .; Pokaż więcej
Źródło:: Translational neurodegeneration [Transl Neurodegener] 2020 Jun 23; Vol. 9 (1), pp. 27. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Heterozygote*
Cerebrospinal Fluid Proteins/*cerebrospinal fluid
Cerebrospinal Fluid Proteins/*genetics
Frontotemporal Dementia/*cerebrospinal fluid
Frontotemporal Dementia/*genetics
Mutation/*genetics
Adult ; Aged ; Biomarkers/cerebrospinal fluid ; Cohort Studies ; Female ; Genetic Testing/methods ; Humans ; Male ; Middle Aged ; Pilot Projects ; Prodromal Symptoms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics.
Autorzy:: van der Ende EL; Department of Neurology Erasmus Medical Center PO Box 2040 3015 GD Rotterdam The Netherlands.
Meeter LH; Department of Neurology Erasmus Medical Center PO Box 2040 3015 GD Rotterdam The Netherlands.
Stingl C; Laboratory of Neuro-oncology Clinical and Cancer Proteomics Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam The Netherlands.
van Rooij JGJ; Department of Neurology Erasmus Medical Center PO Box 2040 3015 GD Rotterdam The Netherlands.; Department of Internal Medicine Erasmus Medical Center PO Box 2040 3015 GD Rotterdam The Netherlands.
Stoop MP; Laboratory of Neuro-oncology Clinical and Cancer Proteomics Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam The Netherlands.
Nijholt DAT; Laboratory of Neuro-oncology Clinical and Cancer Proteomics Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam The Netherlands.
Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit Department of Neurology Hospital Clínic Institut d'Investigació Biomèdica August Pi i Sunyer Villarroel, 170 08036 Barcelona Spain.
Graff C; Division of Neurogeriatrics Department NVS Karolinska Institutet Center for Alzheimer Research Visionsgatan 4 171 64 Solna Stockholm Sweden.; Unit for Hereditary Dementias Theme Aging Karolinska University Hospital-Solna 171 64 Stockholm Sweden.
Öijerstedt L; Division of Neurogeriatrics Department NVS Karolinska Institutet Center for Alzheimer Research Visionsgatan 4 171 64 Solna Stockholm Sweden.; Unit for Hereditary Dementias Theme Aging Karolinska University Hospital-Solna 171 64 Stockholm Sweden.
Grossman M; Department of Neurology Penn Frontotemporal Degeneration Center University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania.
McMillan C; Department of Neurology Penn Frontotemporal Degeneration Center University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania.
Pijnenburg YAL; Alzheimer Center and Department of Neurology Neuroscience Campus Amsterdam VU University Medical Center PO Box 7057 1007 MB Amsterdam The Netherlands.
Laforce R Jr; Clinique Interdisciplinaire de Mémoire (CIME) CHU de Québec Département des Sciences Neurologiques Université Laval Québec Québec Canada.
Binetti G; Molecular Markers Laboratory IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy.; MAC Memory Clinic IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy.
Benussi L; Molecular Markers Laboratory IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy.
Ghidoni R; Molecular Markers Laboratory IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli via Pilastroni 4 Brescia 25125 Italy.
Luider TM; Laboratory of Neuro-oncology Clinical and Cancer Proteomics Department of Neurology Erasmus Medical Center PO Box 2040 3000 CA Rotterdam The Netherlands.
Seelaar H; Department of Neurology Erasmus Medical Center PO Box 2040 3015 GD Rotterdam The Netherlands.
van Swieten JC; Department of Neurology Erasmus Medical Center PO Box 2040 3015 GD Rotterdam The Netherlands.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2019 Mar 07; Vol. 6 (4), pp. 698-707. Date of Electronic Publication: 2019 Mar 07 (Print Publication: 2019).
Typ publikacji:: Journal Article
MeSH Terms:: Proteomics*/methods
Biomarkers/*cerebrospinal fluid
Frontotemporal Dementia/*cerebrospinal fluid
Frontotemporal Dementia/*genetics
Adult ; Aged ; C9orf72 Protein/genetics ; Cohort Studies ; Female ; Heterozygote ; Humans ; Intercellular Signaling Peptides and Proteins/genetics ; Male ; Middle Aged ; Mutation/genetics ; Pick Disease of the Brain/cerebrospinal fluid ; Pick Disease of the Brain/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.
Autorzy:: Fumagalli GG; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy. .; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy. .; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy. .
Basilico P; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Arighi A; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Bocchetta M; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
Dick KM; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
Cash DM; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
Harding S; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
Mercurio M; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Fenoglio C; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Pietroboni AM; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Ghezzi L; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
van Swieten J; Erasmus Medical Center, Rotterdam, The Netherlands.
Borroni B; University of Brescia, Brescia, Italy.
de Mendonça A; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Masellis M; Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
Rowe JB; University of Cambridge, Cambridge, UK.
Graff C; Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden.
Tagliavini F; Istituto Neurologico Carlo Besta, Milan, Italy.
Frisoni GB; IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
Laforce R Jr; Université Laval, Quebec, QC, Canada.
Finger E; University of Western Ontario, London, ON, Canada.
Sorbi S; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; IRCCS Don Gnocchi, Florence, Italy.
Scarpini E; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
Galimberti D; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, University of Milan, Milan, Italy.; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.; Pokaż więcej
Corporate Authors:: Genetic FTD Initiative (GENFI)
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2018 May 24; Vol. 10 (1), pp. 46. Date of Electronic Publication: 2018 May 24.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Brain/*pathology
Frontotemporal Dementia/*complications
Frontotemporal Dementia/*genetics
tau Proteins/*genetics
Adult ; Atrophy/classification ; Atrophy/diagnostic imaging ; Atrophy/etiology ; Brain/diagnostic imaging ; Cohort Studies ; Female ; Frontotemporal Dementia/diagnostic imaging ; Humans ; International Cooperation ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Progranulins/genetics ; RNA-Binding Proteins/genetics ; Severity of Illness Index ; Statistics, Nonparametric

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 18.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Graff C"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język